From October 1, 2022 to December 31, 2022, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 5,260,910 shares, representing 0.9% for CNY 243.27 million under the buyback announced on March 19, 2022.
Autobio Diagnostics Co., Ltd.
Equities
603658
CNE100002GC4
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
50.1 CNY | -2.05% | -2.17% | -12.12% |
May. 21 | Autobio Diagnostics' Unit Gets Nod for Two Products | MT |
Apr. 19 | Autobio Diagnostics' Q1 Profit Jumps 34% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.12% | 4.1B | |
-5.37% | 12.35B | |
-3.75% | 8.17B | |
+7.79% | 5.77B | |
+33.10% | 5.65B | |
+14.18% | 2.67B | |
-5.70% | 2.31B | |
+18.60% | 2.02B | |
-6.70% | 1.81B | |
-3.89% | 1.51B |
- Stock Market
- Equities
- 603658 Stock
- News Autobio Diagnostics Co., Ltd.
- Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on March 19, 2022.